Alpha Tau Medical Ltd. (DRTS)
NASDAQ: DRTS · Real-Time Price · USD
3.360
-0.060 (-1.75%)
Aug 14, 2025, 11:46 AM - Market open
Alpha Tau Medical Employees
Alpha Tau Medical had 125 employees as of December 31, 2024. The number of employees increased by 4 or 3.31% compared to the previous year.
Employees
125
Change (1Y)
4
Growth (1Y)
3.31%
Revenue / Employee
n/a
Profits / Employee
-$281,640
Market Cap
285.75M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 125 | 4 | 3.31% |
Dec 31, 2023 | 121 | 27 | 28.72% |
Dec 31, 2022 | 94 | 11 | 13.25% |
Dec 31, 2021 | 83 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
DRTS News
- 2 days ago - Alpha Tau Announces Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 20 days ago - Revival Healthcare Capital Announces Strategic Partnership to Accelerate External Innovation in Robotics With up to $458 Million Joint Investment With Olympus Into Co-Founded New Company Swan EndoSurgical - Business Wire
- 3 months ago - Alpha Tau Announces First Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 3 months ago - Alpha Tau Announces Appointment of Nadav Kidron to its Board of Directors - GlobeNewsWire
- 3 months ago - Alpha Tau to Participate in May Investor Conferences - GlobeNewsWire
- 3 months ago - Oramed Pharmaceuticals Announces $36.9 Million Investment and Strategic Collaboration with Alpha Tau Medical - PRNewsWire
- 3 months ago - Alpha Tau Announces Closing of $36.9 Million Registered Direct Offering and Strategic Marketing Alliance with Oramed Pharmaceuticals - GlobeNewsWire
- 4 months ago - Alpha Tau Receives FDA Approval to Initiate a Trial for Patients with Recurrent Glioblastoma - GlobeNewsWire